Markets:

Overview

News

Currencies

International

Treasuries

Emergent BioSolutions Inc. Common Stock (NY:EBS)

5.830 +0.190 (+3.37%)

Streaming Delayed Price Updated: 1:56 PM EDT, Aug 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Emergent BioSolutions Inc. Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

WHO Says Monkeypox Outbreak 'Unusual' But 'Containable' ↗

May 24, 2022

The World Health Organization (WHO) said that there had been 131 confirmed monkeypox cases and 106 further suspected cases,

Via Benzinga

Why Emergent Biosolutions Stock Is Rising Today ↗

May 23, 2022

Emergent Biosolutions Inc (NYSE: EBS) shares are trading higher Monday amid increasing monkeypox concerns.

Via Benzinga

24 Stocks Moving in Monday's Pre-Market Session ↗

May 23, 2022

Gainers Genocea Biosciences, Inc. (NASDAQ: GNCA) shares rose 33.8% to $0.2795 in pre-market trading after declining around 5% on Friday.

Via Benzinga

6 Stocks To Watch Amid Monkeypox Outbreak ↗

May 20, 2022

A Monkeypox outbreak has been reported in several European countries, two cases in Canada and one confirmed case in a man from Massachusetts.

Via Benzinga

Stock Market Recap: This Week’s 5 Top Stories ↗

May 20, 2022

It's been a busy week for the stock market and we're going over all the latest news that investors need to know about with a recap!

Via InvestorPlace

Monkeypox Stocks: SIGA, EBS and TNXP Move Higher on Smallpox Vaccines, Treatments ↗

May 20, 2022

Monkeypox stocks SIGA, EBS and TNXP are all advancing as fears mount over monkeypox. The disease is related to smallpox.

Via InvestorPlace

71 Biggest Movers From Yesterday ↗

May 20, 2022

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation...

Via Benzinga

38 Stocks Moving In Thursday's Mid-Day Session ↗

May 19, 2022

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for...

Via Benzinga

What Is Monkeypox Virus That Is Spreading in Europe, US ↗

May 19, 2022

Monkeypox was first discovered in the late 1950s after cropping up among monkeys kept for research. Like smallpox and chickenpox, it is characterized by flu-like symptoms and pus-filled blisters and...

Via Benzinga

Mid-Afternoon Market Update: Dow Jumps 300 Points; Crude Oil Rises Over 3% ↗

May 16, 2022

U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 300 points on Monday.

Via Benzinga

73 Biggest Movers From Yesterday ↗

May 17, 2022

Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on Friday.

Via Benzinga

Mid-Day Market Update: Dow Edges Higher; Data Storage Shares Surge ↗

May 16, 2022

U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 20 points on Monday.

Via Benzinga

41 Stocks Moving In Monday's Mid-Day Session ↗

May 16, 2022

Gainers Data Storage Corporation (NASDAQ: DTST) shares jumped 51.1% to $3.4750 after the company reported better-than-expected Q1 financial results.

Via Benzinga

Mid-Morning Market Update: Markets Open Lower; Dow Drops 70 Points ↗

May 16, 2022

U.S. stocks traded lower this morning, with the Nasdaq Composite adding more than 400 points on Friday.

Via Benzinga

7 High-Risk, High-Reward Small-Cap Stocks to Buy Now ↗

May 13, 2022

Many small-cap stocks in the S&P 600 Small Cap Index aren't big names, but they have the change of bringing big rewards.

Via InvestorPlace

Almost 400M COVID-19 Vaccine Doses Lost Due To Emergent's Baltimore Plant Fiasco ↗

May 11, 2022

Via Benzinga

Emergent BioSolutions Suspends CDMO Guidance As It Awaits Clarity On COVID-19 Vaccine Requirements ↗

April 29, 2022

Via Benzinga

5 Value Stocks In The Healthcare Sector ↗

April 25, 2022

What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

The Daily Biotech Pulse: Valneva Gains On COVID Shot Regulatory Update, Lucira Health And Clearside Jump On Earnings, BeiGene Drug Snags Approval In China ↗

March 11, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Valneva Says Confident Of Conditional Approval For COVID Vaccine Candidate In...

Via Benzinga

Emergent BioSolutions: Q4 Earnings Insights ↗

February 24, 2022

Emergent BioSolutions (NYSE:EBS) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement....

Via Benzinga

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company ↗

February 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...

Via Benzinga

Johnson & Johnson's COVID-19 Shot Wins Its First Full Approval In Canada ↗

November 24, 2021

Canada has become the first country to fully approve Johnson & Johnson's (NYSE: JNJ) single-dose Covid-19 vaccine. According to a statement, regulators...

Via Benzinga

Why Emergent BioSolutions Popped by Over 4% Today ↗

November 12, 2021

The company has given 250 million reasons why investors should buy its stock.

Via The Motley Fool

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares ↗

November 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus J&J to Separate Its Consumer Health Business Into a New Publicly Traded...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2021 ↗

November 08, 2021

Upgrades For Nektar Therapeutics (NASDAQ:

Via Benzinga

See Why Emergent BioSolutions Stock Plunged 37% On Friday? ↗

November 05, 2021

After a fiasco surrounding the contamination of COVID-19 vaccine doses in its facilities, Emergent BioSolutions Inc's (NYSE: EBS) manufacturing deal with the US...

Via Benzinga

Mid-Afternoon Market Update: Dow Surges 200 Points; Grid Dynamics Shares Spike Higher ↗

November 05, 2021

Toward the end of trading Friday, the Dow traded up 0.57% to 36,331.86 while the NASDAQ rose 0.20% to 15,972.41. The S&P also rose, gaining 0.40% to 4,698.70. The U.S. has the...

Via Benzinga

Topics Stocks

92 Biggest Movers From Friday ↗

November 08, 2021

Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares jumped 99.8% to close at $9.99 on Friday. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 05, 2021

Gainers Chinook Therapeutics (NASDAQ:KDNY) shares increased by 28.75% to $15.76 during Friday's regular session. Trading volume for this security as of 12:30 EST is 1....

Via Benzinga

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.